Contract 36C26025F0007
Otsuka America Pharmaceutical Inc · Department Of Veterans Affairs · October 1, 2024
Otsuka America Pharmaceutical Inc was awarded a federal contract by Department Of Veterans Affairs on October 1, 2024 for $361,000 of work in pharmaceutical preparation manufacturing. Performance is in Orlando, FL. This is a task or delivery order issued under parent IDIQ 36F79720D0099. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 6, 2026. If all options are exercised, the contract could reach $638,000.
Contract details
- PIID
- 36C26025F0007
- Parent IDIQ
- 36F79720D0099
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Orlando, FL
- First action
- October 1, 2024
- Latest action
- March 6, 2026
Description
JYNARQUE - BULK- 2025 PRICE INCREASE
Modification timeline
-
March 6, 2026Mod P00002 · Other Administrative Action$637.7K
-
October 1, 2024Base award$453.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C26025F0007?
Contract 36C26025F0007 is a federal contract awarded to Otsuka America Pharmaceutical Inc by Department Of Veterans Affairs on October 1, 2024 for $361,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 36C26025F0007?
Otsuka America Pharmaceutical Inc won contract 36C26025F0007 from Department Of Veterans Affairs.
How much is contract 36C26025F0007 worth?
Contract 36C26025F0007 has obligated $361,000 to date, with a total potential value of $638,000 if all options are exercised.